In addition, in MI patients undergoing coronary artery bypass grafting (CABG), IL-18 in systemic circulation leads to the activation of lymphocyte cytotoxicity, then enhancing circulating lymphocyte activity [99]. Here, IL18 is linked to myocardial infarction.